{
  "retracted": false,
  "timestamp": 1501545600000,
  "updates": [
    {
      "timestamp": 1585432387918,
      "identifier": {
        "doi": "10.1158/2159-8290.cd-17-0566"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1158/2159-8290.cd-nb2016-080"
  },
  "publisher": "American Association for Cancer Research (AACR)",
  "title": "Correction: Nods for Atezolizumab and Nivolumab from FDA"
}
